79
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Presepsin Level Correlates with the Development of Moderate Coronary Artery Calcifications in Hemodialysis Patients: A Preliminary Cross-Section Design Study

, ORCID Icon, , , &
Pages 999-1006 | Published online: 03 Aug 2020

References

  • United States Renal Data System. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018.
  • Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):S112–S119. doi:10.1053/ajkd.1998.v32.pm98204709820470
  • London GM, Marchais SJ, Guérin AP, Métivier F. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens. 2005;14:525–531. doi:10.1097/01.mnh.j0000168336.67499.c016205470
  • Blacher J, Guérin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938–942. doi:10.1161/hy1001.09635811641313
  • Kobayashi S. Cardiovascular events in hemodialysis patients: challenging against vascular calcification. Ann Vasc Dis. 2017;10(1):1–7. doi:10.3400/avd.ra.17-0000629034013
  • Hsu JJ, Lim J, Tintut Y, Demer LL. Cell-matrix mechanics and pattern formation in inflammatory cardiovascular calcification. Heart. 2016;102(21):1710–1715. doi:10.1136/heartjnl-2016-30966727406839
  • Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109:697–711. doi:10.1161/CIRCRESAHA.110.23491421885837
  • Nakamura S, Ishibashi-Ueda H, Niizuma S, Yoshihara F, Horio T, Kawano Y. Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol. 2009;4:1892–1900. doi:10.2215/CJN.0432070919833908
  • Coll B, Betriu A, Martínez-Alonso M, et al. Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis. Clin J Am Soc Nephrol. 2011;6:303–310. doi:10.2215/CJN.0429051020930091
  • Benz K, Hilgers KF, Daniel C, Amann K. Vascular calcification in chronic kidney disease: the role of inflammation. Int J Nephrol. 2018;2018:4310379. doi:10.1155/2018/431037930186632
  • Cianciolo G, Capelli I, Cappuccilli M, Schillaci R, Cozzolino M, La Manna G. Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients. Clin Kidney J. 2016;9:280–286. doi:10.1093/ckj/sfv14526985381
  • Liu B, Chen YX, Yin Q, Zhao YZ, Li CS. Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department. Crit Care. 2013;17:R244. doi:10.1186/cc1307024138799
  • Romualdo LG, Torrella PE, González MV, et al. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the emergency department. Clin Biochem. 2014;47:505–508. doi:10.1016/j.clinbiochem.2014.02.01124560955
  • Ulla M, Pizzolato E, Lucchiari M, et al. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care. 2013;17:R168. doi:10.1186/cc1284723899120
  • Reiner AP, Lange EM, Jenny NS, et al. Soluble CD14. Genomewide association analysis and relationship to cardiovascular risk and mortality in older adults. Arterioscler Thromb Vasc Biol. 2013;33:158–164. doi:10.1161/ATVBAHA.112.30042123162014
  • Chenevier-Gobeaux C, Trabattoni E, Roelens M, Borderie D, Claessens YE. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values? Clin Chim Acta. 2014;427:34–36. doi:10.1016/j.cca.2013.09.01924076253
  • Nagata T, Yasuda Y, Ando M, et al. Clinical impact of kidney function on presepsin levels. PLoS One. 2015;10(6):e0129159. doi:10.1371/journal.pone.012915926030716
  • Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999;74(3):243–252. doi:10.4065/74.3.24310089993
  • Miyoshi M, Inoue Y, Nishioka M, et al. Clinical evaluation of presepsin considering renal function. PLoS One. 2019;14(9):e0215791. doi:10.1371/journal.pone.021579131490935
  • Nakayama M, Ura Y, Nagata M, et al. Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study. BMC Nephrol. 2011;12:56. doi:10.1186/1471-2369-12-5621999942
  • Kobayashi S, Amano H, Terawaki H, Kawaguchi Y, Yokoo T. Prediction of presepsin concentrations through commensurate decline in kidney function in the elderly. Clin Chim Acta. 2020;500:1–9. doi:10.1016/j.cca.2019.09.01231593686
  • Jofré R, Rodriguez-Benitez P, López-Gómez JM, Pérez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006;17(12 Suppl 3):S274–S280. doi:10.1681/ASN.200608092617130274
  • Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Naive and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006;70:371–376. doi:10.1038/sj.ki.500155016738532
  • Betjes MG, Huisman M, Weimar W, Litjens NH. Expansion of cytolytic CD4+CD28- T cells in end-stage renal disease. Kidney Int. 2008;74:760–767. doi:10.1038/ki.2008.30118615000
  • Meijers RW, Litjens NH, de Wit EA, et al. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients. Immun Ageing. 2012;9:19. doi:10.1186/1742-4933-9-1922971545
  • Angeletti A, Zappulo F, Donadei C, et al. Immunological effects of a single hemodialysis treatment. Medicina (Kaunas). 2020;56(2):71. doi:10.3390/medicina56020071
  • Block GA, Spiegel DM, Ehrlich J, et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005;68:1815–1824. doi:10.1111/j.1523-1755.2005.00600.x16164659
  • Alesutan I, Luong TTD, Schelski N, et al. Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signaling. Cardiovasc Res. 2020:pii: cvaa081. doi:10.1093/cvr/cvaa081.
  • Vervloet M, Cozzolino M. Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int. 2017;91:808–817. doi:10.1016/j.kint.2016.09.02427914706